Severe Combined Immunodeficiency (SCID) is a group of disorders caused by defects in genes involved in the development and function of T-cells and other infection-fighting immune cells.
Recent Media Coverage
Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.
Robert Roe investigates cloud and SaaS deployment models and the inherent flexibility and scalability they provide to users.
US-based PerkinElmer, Inc. (NYSE: PKI) has completed its acquisition of Sweden-based analytical instruments supplier Perten Instruments Group AB. The deal is worth around USD 266m. Perten supplies instruments for quality control of food, grain, flour and feed.
OncoSec Medical Inc, San Diego, a company developing DNA-based intratumoral cancer immunotherapies, recently announced a collaboration with PerkinElmer Inc and the University of California, Los Angeles (UCLA), to help researchers develop biomarker tests for evaluating a patient’s immune response to cancer.
PerkinElmer has acquired Perten Instruments for $266m to ‘significantly expand’ its presence in the food testing.
PerkinElmer Inc. (PKI) on Thursday reported third-quarter profit of $42.3 million. The results met Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was also for earnings of 57 cents per share.
Perkin Elmer has unveiled its Solaris quantitative optical molecular imaging system for use in small and large animal studies. The Solaris system can bridge molecular imaging research techniques to support potential clinical outcomes.
After a generation of outsourcing services to lower-cost providers, smart companies now realize that they need to reassess this strategy. Outsourcing did lower costs in a time of need, but it came at a high price.
Technology and humans have a two-way action/reaction relationship. Given the concerns over the quality of the air we breathe, one company has developed a small device that can measure local conditions.